May 10, 2013: 
Novel screening program prevents admissions to the hospital
Hvidovre University Hospital*, Denmark is implementing the suPAR biomarker as part of their new screening program for optimized patient identification and treatment. A simple physical test in connection with suPAR will help physicians to simplify efforts to identify the right patients for admission into the hospital, furthermore will the addition of suPAR help to introduce more objective parameters for triaging patients into the hospital.
The Director of Research at Hvidovre Hospital, Ove Andersen, says that the hospital will need to move away from acute and very organ specific parameters when assessing the patients, and focus more on the overall health status of the patients. Many of the patients are suffering from comorbidities, and hence it is important to make an overall assessment. The objective nature of the suPAR test will help to offer more equal treatment opportunities for all patients, irrespective of their capability to communicate their clinical symptoms in the right manner, says Dr. Andersen.
*Hvidovre Hospital is one of the largest teaching hospitals in Denmark with an uptake population of around 0,5 mio people.
Please find more information in the Danish article here:
"Ny screeningstest skal forebygge indlæggelser af skrøbelige ældre"
______________________________________________________________________
October 18, 2012:
"suPAR - en helt ny måde at tænke sygdom på"
Read the Danish article from the magazine Praksis, Erhvervsmagasinet for private speciallægeklinikker, October 2012:
"suPAR - en helt ny måde at tænke sygdom på". An interview with Jesper Eugen-Olsen about the amount of inflammation in the body and the prognostic value of the suPAR test.
20121018 suPAR in magazine Praksis
______________________________________________________________________
August 28, 2012:
"Dansk opfindelse kan fange sygdomssignaler i opløbet"
Read the Danish article from Opfinderrådgivningen, Teknologisk Institut, of the story behind suPARnostic® and the launch of the latest product, suPARnostic® Quick Triage.
20120828 Ingeniøren article
______________________________________________________________________
August 27, 2012:
The new suPARnostic® Quick Triage Test provide strong support for the Emergency Room
A key challenge for the medical section within the Emergency Room is to accurately triage patients for either hospital admittance or acquittal. ER Medical staff faces mainly patients with cardiovascular disease (CVD), organ dysfunctions or infections (including sepsis) and need to quickly and efficiently triage to secure optimal patient outcome, minimize re-admissions and secure efficient resource allocation.
The suPARnostic® test has proven to be a strong predictor of disease progression in critically ill patients, as elevated plasma suPAR levels reflect a developing critical condition and has repeatedly shown to correlate significantly with patient disease severity.
suPARnostic® Quick Triage – Point of Care Test Device for early Warning and Intervention
The new Point of Care device, suPARnostic® Quick Triage, is easy to use and will allow clinicians and nurses to perform the test in the Emergency Room instead of having to go via the clinical laboratory.
The easy to use test device offers a short and simple procedure with a single cut-off point enabling the personnel at the Emergency Room to act immediately if suPAR levels are abnormal. Early test results will improve the decision making process for the patient procedure.
"ViroGates launches suPARnostic® Quick Triage product, receives product approval in Canada and enters into distribution agreement with Cedarlane"
Read the Press Release here:
20120827 Press Release ViroGates: Product launch and Canda registration
"ViroGates lancerer nyt produkt der vil hjælpe alle akutmedicinske patienter til bedre behandling"
Læs pressemeddelelse her:
20120827 Press Release ViroGates: Nyt produkt og registrering i Canada
______________________________________________________________________
August 24, 2012:
"Medico-firma klar til markedsføring i USA og Canada"
Read the Danish article in MedWatch about ViroGates registration with Health Canada and distribution agreement with Cedarlane in Canada and USA.
20120824 Medwatch article
______________________________________________________________________
August 8, 2012:
"Dansk firma klar med værktøj til hurtig test af helbredsstatus"
Read the Danish article in MedWatch; an interview with Jakob Knudsen about the launch of ViroGates new suPARnostic® Quick Triage Test.
20120808 Medwatch article
______________________________________________________________________
